LY2828360

DB16074InvestigationalSmall molecule

LY2828360 is under investigation in clinical trial NCT01319929 (A Study of LY2828360 in Patients With Osteoarthritic Knee Pain).

Chemical structure of LY2828360
Mechanism
Curator reviewed
Formula / weight
C22H27ClN6O · 426.95 g/mol (avg)
Code names
LY-2828360

Resolves to

Compound
UNIIO12H7VFU6PCAS1231220-79-3ChEMBLCHEMBL3139186
Structure
InChIKeyUCMNDPDJRSEZPL-UHFFFAOYSA-NSMILESCN1CCN(CC1)C1=C2N=C(N(C3CCOCC3)C2=NC(C)=N1)C1=CC=CC=C1Cl
Targets
P34972CNR2

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with LY2828360, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In